Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy
Original Article from The New England Journal of Medicine — Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 13, 2018
|
| In: |
The New England journal of medicine
Year: 2018, Volume: 379, Issue: 11, Pages: 1007-1016 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1805689 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1056/NEJMoa1805689 Verlag, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1805689 
|
| Author Notes: | Mathew S. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry M. Elliott, Giampaolo Merlini, Marcia Waddington-Cruz, Arnt V. Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy, Brian M. Drachman, Sanjiv J. Shah, Mazen Hanna, Daniel P. Judge, Alexandra I. Barsdorf, Peter Huber, Terrell A. Patterson, Steven Riley, Jennifer Schumacher, Michelle Stewart, Marla B. Sultan, and Claudio Rapezzi for the ATTR-ACT study investigators |
| Summary: | Original Article from The New England Journal of Medicine — Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy |
|---|---|
| Item Description: | Gesehen am 18.10.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1805689 |